IMU Imugene Receives Orphan Drug Designation for VAXINIA 18/09/24 PRICE SENSITIVE download Created with Sketch. 237.05KB Share IMU Three Complete Responses in Azer-Cel Phase 1b Trial 02/09/24 PRICE SENSITIVE download Created with Sketch. 319.48KB Share IMU Appendix 4E and Annual Report 30/08/24 PRICE SENSITIVE download Created with Sketch. 5.58MB Share IMU Quarterly Activities/Appendix 4C Cash Flow Report 31/07/24 PRICE SENSITIVE download Created with Sketch. 458.91KB Share IMU First patient dosed in Phase 1 bile tract cancer trial 10/07/24 PRICE SENSITIVE download Created with Sketch. 368.53KB Share IMU Imugene onCARlytics Doses First Patient in IV Combination 24/06/24 PRICE SENSITIVE download Created with Sketch. 169.93KB Share IMU Quarterly Activities/Appendix 4C Cash Flow Report 30/04/24 PRICE SENSITIVE download Created with Sketch. 484.57KB Share IMU Imugene and Kincell Bio Announce Strategic Partnership 16/04/24 PRICE SENSITIVE download Created with Sketch. 220.02KB Share IMU Bile Tract Cancer Study Opens after MAST High Dose Clearance 15/04/24 PRICE SENSITIVE download Created with Sketch. 217.25KB Share IMU VAXINIA and HER-Vaxx featured at the AACR Annual Meeting 08/04/24 PRICE SENSITIVE download Created with Sketch. 173.17KB Share IMU Oncolytic Virotherapy CF33 Patent Granted in China 04/04/24 PRICE SENSITIVE download Created with Sketch. 163.48KB Share IMU Imugene to present at 2024 Cholangiocarcinoma Conference 03/04/24 PRICE SENSITIVE download Created with Sketch. 161.29KB Share IMU Phase 1 onCARlytics Trial Advances to Combination Arm 11/03/24 PRICE SENSITIVE download Created with Sketch. 193.84KB Share IMU Half Yearly Report and Accounts 29/02/24 PRICE SENSITIVE download Created with Sketch. 1.15MB Share IMU Phase 1 onCARlytics Trial Doses First Intravenous Patient 15/02/24 PRICE SENSITIVE download Created with Sketch. 192.99KB Share IMU Quarterly Activities/Appendix 4C Cash Flow Report 31/01/24 PRICE SENSITIVE download Created with Sketch. 488.54KB Share IMU VAXINIA Phase 1 trial doses patients in higher dose cohorts 19/01/24 PRICE SENSITIVE download Created with Sketch. 239.95KB Share IMU Phase 1 CF33-hNIS Study Update - Positive Early Signals 17/01/24 PRICE SENSITIVE download Created with Sketch. 181.6KB Share IMU Imugene and NeoImmuneTech to Improve Cancer Treatments 12/12/23 PRICE SENSITIVE download Created with Sketch. 193KB Share IMU New PD1-Vaxx Phase 2 CRC Cancer Trial to Open in UK and AUS 06/12/23 PRICE SENSITIVE download Created with Sketch. 176.65KB Share IMU Europe Patent to be Granted for PD1-Vaxx Cancer Vaccine 06/12/23 PRICE SENSITIVE download Created with Sketch. 127.27KB Share IMU FDA Fast Track Designation Granted for VAXINIA Trial Program 28/11/23 PRICE SENSITIVE download Created with Sketch. 161.6KB Share IMU Azer-cel Hits Major Milestone in Phase 1b CAR T Trial 10/11/23 PRICE SENSITIVE download Created with Sketch. 193.03KB Share IMU Phase 1 CF33 VAXINIA Study Update - Positive Early Signals 06/11/23 PRICE SENSITIVE download Created with Sketch. 179.05KB Share IMU Next cohort reached in IV arms of CF33-hNIS (VAXINIA) study 02/11/23 PRICE SENSITIVE download Created with Sketch. 174.52KB Share IMU Quarterly Activities/Appendix 4C Cash Flow Report 31/10/23 PRICE SENSITIVE download Created with Sketch. 488.42KB Share IMU Imugene Phase 1 onCARlytics CD19 virus clinical trial opens 26/10/23 PRICE SENSITIVE download Created with Sketch. 148.52KB Share IMU Imugene B Cell & OV Platforms Featured at ESMO Congress 24/10/23 PRICE SENSITIVE download Created with Sketch. 172.35KB Share IMU Azer-cel FDA IND Transferred to Imugene 28/09/23 PRICE SENSITIVE download Created with Sketch. 148.99KB Share IMU Imugene Closes SPP Raising $18.2 million 25/09/23 PRICE SENSITIVE download Created with Sketch. 118.78KB Share IMU Imugene PD1-Vaxx Update 12/09/23 PRICE SENSITIVE download Created with Sketch. 137.53KB Share IMU Imugene Receives Positive Feedback From FDA 11/09/23 PRICE SENSITIVE download Created with Sketch. 170.25KB Share IMU VAXINIA MAST Trial Clears Intratumoral Combination Cohort 1 04/09/23 PRICE SENSITIVE download Created with Sketch. 156.91KB Share IMU S&P DJI Announces September 2023 Quarterly Rebalance 01/09/23 PRICE SENSITIVE download Created with Sketch. 121.59KB Share IMU Prospectus 25/08/23 PRICE SENSITIVE download Created with Sketch. 665.61KB Share IMU Preliminary Final Report 25/08/23 PRICE SENSITIVE download Created with Sketch. 2.27MB Share IMU Imugene Capital Raising Presentation 18/08/23 PRICE SENSITIVE download Created with Sketch. 2.05MB Share IMU Imugene completes $35M Placement & Launches c.$30M SPP 18/08/23 PRICE SENSITIVE download Created with Sketch. 267.71KB Share IMU Imugene Licenses Allogeneic CD19 CAR T Cell Therapy 16/08/23 PRICE SENSITIVE download Created with Sketch. 178.46KB Share IMU Trading Halt 16/08/23 PRICE SENSITIVE download Created with Sketch. 211.29KB Share IMU Imugene VAXINIA Trial clears Cohort 3 of IT Monotherapy 14/08/23 PRICE SENSITIVE download Created with Sketch. 193.5KB Share IMU Imugene CF33 Oncolytic Virus Study to be Showcased at SITC 03/08/23 PRICE SENSITIVE download Created with Sketch. 134.84KB Share IMU Imugene HER-Vaxx and CHECKVacc to be Featured at ESMO 24/07/23 PRICE SENSITIVE download Created with Sketch. 142.89KB Share IMU Quarterly Activities/Appendix 4C Cash Flow Report 21/07/23 PRICE SENSITIVE download Created with Sketch. 1.4MB Share IMU Imugene and RenovoRx CF33 Virotherapy Delivery Collaboration 20/07/23 PRICE SENSITIVE download Created with Sketch. 250.08KB Share IMU Imugene Oncolytic Virotherapy CF33 Patent Allowed in the US 19/07/23 PRICE SENSITIVE download Created with Sketch. 148.79KB Share IMU New Dose Escalation in Phase I Clinical Trial of CHECKvacc 07/07/23 PRICE SENSITIVE download Created with Sketch. 135.06KB Share IMU HER-Vaxx induced antibodies correlated with tumour reduction 30/06/23 PRICE SENSITIVE download Created with Sketch. 145.8KB Share IMU Imugene PD1-Vaxx patent extended to 2040 29/06/23 PRICE SENSITIVE download Created with Sketch. 119.39KB Share IMU Imugene Advances VAXINIA MAST Trial to Next IV Cohorts 09/06/23 PRICE SENSITIVE download Created with Sketch. 164.13KB Share IMU Imugene doses first combination patient in PD1-Vaxx trial 01/06/23 PRICE SENSITIVE download Created with Sketch. 150.45KB Share IMU FDA clears Imugene IND for onCARlytics first-in-class study 19/05/23 PRICE SENSITIVE download Created with Sketch. 285.34KB Share IMU onCARlytics with ARTEMIS T cells show anti-tumour activity 18/05/23 PRICE SENSITIVE download Created with Sketch. 135.87KB Share IMU onCARlytics with Artemis T cells abstract presented at ASGCT 03/05/23 PRICE SENSITIVE download Created with Sketch. 127.55KB Share IMU Quarterly Activities/Appendix 4C Cash Flow Report 28/04/23 PRICE SENSITIVE download Created with Sketch. 1.33MB Share IMU Imugene receives $12.6m R&D tax refund 26/04/23 PRICE SENSITIVE download Created with Sketch. 131.8KB Share IMU Imugene Images and Follows CHECKVacc in TNBC Patients 20/04/23 PRICE SENSITIVE download Created with Sketch. 151.57KB Share IMU First patients dosed in IT & IV cohort 3 of VAXINIA trial 05/04/23 PRICE SENSITIVE download Created with Sketch. 499.46KB Share IMU First Patients Dosed in Combination Study of VAXINIA 03/03/23 PRICE SENSITIVE download Created with Sketch. 195.69KB Share IMU Half Yearly Report and Accounts 28/02/23 PRICE SENSITIVE download Created with Sketch. 1.12MB Share IMU Imugene PD1-Vaxx Immunotherapy Patent Granted in the US 10/02/23 PRICE SENSITIVE download Created with Sketch. 126.56KB Share IMU Imugene VAXINIA trial advances to Combination Cohort 02/02/23 PRICE SENSITIVE download Created with Sketch. 194.71KB Share IMU Quarterly Activities/Appendix 4C Cash Flow Report 27/01/23 PRICE SENSITIVE download Created with Sketch. 458.7KB Share IMU Imugene Receives Vaxinia Ethics Approval in Australia 09/01/23 PRICE SENSITIVE download Created with Sketch. 202.94KB Share IMU CHECKVacc Data Presented at the 2022 SABC Symposium 09/12/22 PRICE SENSITIVE download Created with Sketch. 252.41KB Share IMU First Patient Dosed in VAXINIA Intravenous Cohort 2 05/12/22 PRICE SENSITIVE download Created with Sketch. 250.44KB Share IMU Positive New HER-Vaxx HERIZON Data Presented at ESMO Asia 05/12/22 PRICE SENSITIVE download Created with Sketch. 209.85KB Share IMU Imugene onCARlytics with Estrella ARTEMIS T Cells SITC 14/11/22 PRICE SENSITIVE download Created with Sketch. 255.3KB Share IMU Dose escalates In Phase I Clinical Trial of New Oncolytic Vi 11/11/22 PRICE SENSITIVE download Created with Sketch. 250.51KB Share IMU Imugene onCARlytics with blinatumomab SITC presentation 11/11/22 PRICE SENSITIVE download Created with Sketch. 244.77KB Share IMU Imugene onCARlytics with Celularity CyCART-19 T Cells SITC 11/11/22 PRICE SENSITIVE download Created with Sketch. 306.65KB Share IMU ALA: Europe Patent granted for iNKT Cell Therapy Platform 07/11/22 PRICE SENSITIVE download Created with Sketch. 150.42KB Share IMU First patient dosed in VAXINIA intratumoral cohort 2 31/10/22 PRICE SENSITIVE download Created with Sketch. 228.66KB Share IMU Quarterly Activities/Appendix 4C Cash Flow Report 28/10/22 PRICE SENSITIVE download Created with Sketch. 608KB Share IMU Preclinical trial of ALA iNKT therapy and IMU onCARlytics 26/09/22 PRICE SENSITIVE download Created with Sketch. 219.23KB Share IMU First patient IV dosed in VAXINIA Phase 1 clinical trial 21/09/22 PRICE SENSITIVE download Created with Sketch. 189.98KB Share IMU OGTR grants VAXINIA DIR licence allowing trial expansion 19/09/22 PRICE SENSITIVE download Created with Sketch. 212.02KB Share IMU Prospectus for the issue of institutional placement options 16/09/22 PRICE SENSITIVE download Created with Sketch. 604.08KB Share IMU IMUGENE ANNOUNCES A$80 MILLION INSTITUTIONAL PLACEMENT 13/09/22 PRICE SENSITIVE download Created with Sketch. 361.45KB Share IMU Trading Halt 12/09/22 PRICE SENSITIVE download Created with Sketch. 220.02KB Share IMU Imugene doses first patient in nextHERIZON Phase 2 trial 08/09/22 PRICE SENSITIVE download Created with Sketch. 191.8KB Share IMU Imugene Dose Escalates in Phase I Clinical Trial of VAXINIA 01/09/22 PRICE SENSITIVE download Created with Sketch. 232.91KB Share IMU Annual Report and Appendix 4E 31/08/22 PRICE SENSITIVE download Created with Sketch. 2.3MB Share IMU FIRST COHORT 3 PATIENT DOSED IN CLINICAL TRIAL OF CHECKVACC 10/08/22 PRICE SENSITIVE download Created with Sketch. 196.13KB Share IMU Imugene Presents New PD1-Vaxx Data at the 2022 WCLC 08/08/22 PRICE SENSITIVE download Created with Sketch. 356.21KB Share IMU Quarterly Activities/Appendix 4C Cash Flow Report 25/07/22 PRICE SENSITIVE download Created with Sketch. 837.24KB Share IMU Final HER-Vaxx Phase 2 Trial Overall Survival Results 27/06/22 PRICE SENSITIVE download Created with Sketch. 224.59KB Share IMU IMUGENE DOSES FIRST PATIENT IN VAXINIA PHASE 1 TRIAL 18/05/22 PRICE SENSITIVE download Created with Sketch. 230.78KB Share IMU IMU RECEIVES ETHICS APPROVAL TO START HER-VAXX NextHERIZON 10/05/22 PRICE SENSITIVE download Created with Sketch. 116.77KB Share IMU Response to ASX Query 09/05/22 PRICE SENSITIVE download Created with Sketch. 305.29KB Share IMU Clarification Announcement 03/05/22 PRICE SENSITIVE download Created with Sketch. 165.86KB Share IMU Pause in Trading 03/05/22 PRICE SENSITIVE download Created with Sketch. 115.68KB Share IMU Termination of Supply Agreement 02/05/22 PRICE SENSITIVE download Created with Sketch. 104.46KB Share IMU Quarterly Activities/Appendix 4C Cash Flow Report 22/04/22 PRICE SENSITIVE download Created with Sketch. 3.08MB Share IMU Dose Escalation in Phase 1 Clinical Trial of CHECKvacc 24/03/22 PRICE SENSITIVE download Created with Sketch. 109.98KB Share IMU Clinical Trial of New Cancer Oncolytic Virotherapy Vaxinia 23/03/22 PRICE SENSITIVE download Created with Sketch. 110.26KB Share IMU Imugene HER-Vaxx Clinical Trial Collaboration with Merck 15/03/22 PRICE SENSITIVE download Created with Sketch. 151.02KB Share IMU Half Yearly Report and Accounts 28/02/22 PRICE SENSITIVE download Created with Sketch. 5.61MB Share IMU Oncolytic Virotherapy CF33 Patent Granted in Japan 31/01/22 PRICE SENSITIVE download Created with Sketch. 119.32KB Share IMU Quarterly Activities/Appendix 4C Cash Flow Report 28/01/22 PRICE SENSITIVE download Created with Sketch. 3.82MB Share